Regional differences in hepatitis C treatment with peginterferon and ribavirin in Japan: a retrospective cohort study

Overview of attention for article published in Drug Design, Development and Therapy, March 2016

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 6 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 3 publications that cite this research output.

3

The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.

Regional Differences in the Safety of Telaprevir-Based Triple Therapy for Chronic Hepatitis C in Japan:

Article in Iyakuhin Johogaku (September 2018)

Machine Intelligence in Healthcare and Medical Cyber Physical Systems: A Survey

Article in IEEE Access (January 2018)

Comparison of the safety profiles of pegylated interferon α-2a and α-2b administered in combination with ribavirin for chronic hepatitis C infection: A real-world retrospective cohort study

Article in Biological and Pharmaceutical Bulletin (September 2016)